57
Views
30
CrossRef citations to date
0
Altmetric
Research Article

Incidence of and risk factors for diabetic retinopathy in Isfahan, Iran

, , &
Pages 81-95 | Published online: 08 Jul 2009

References

  • Moss SE, Klein R, Klein BEK. The incidence of vision loss in a diabetic population. Ophthalmology. 1988;95: 1875–1895.
  • Keen H. Prevalence of blindness in diabetics. J Roy Coll Phys London. 1972;7:53–60.
  • Dwyer MS, Melton LJ III, Ballard DJ, Palumbo PJ, Trautmann JC, Chu CP. Incidence of diabetic retinopathy and blindness: A population-based study in Rochester, Minnesota. Diabetes Care. 1985;8:316–322.
  • Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiology study of diabetic retinopathy. III prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol. 1984;102: 527–532.
  • Nguyen HT, Luzio SD, Dolben J, West J, Beck L, Coates PA, Owens DR. Dominant risk factors for retinopathy at clinical diagnosis in patients with type II diabetes mellitus. J Diabetes Complications. 1996;10:221–229.
  • Nagi DK, Pettitt DJ, Bennett PH, Klein R, Knowler WC. Diabetic retinopathy assessed by fundus photography in Pima Indians with impaired glucose tolerance and NIDDM. Diabet Med. 1997;14: 449–456.
  • Klein R, Palta M, Allen C, Shen G, Han DP, D'Alessio DJ. Incidence of retinopathy and associated risk factors from time of diagnosis of insulin-dependent diabetes. Arch Ophthalmol. 1997;115:351–356.
  • Diabetes control and complications trial (DCCT): Update. Diabetes Care. 1990;13:427–433.
  • DCCT Research Group. Epidemiology of severe hypoglycemia in the diabetes control and complications trial. Am J Med. 1991;90:450–451.
  • Lloyd CE, Klein R, Maser RE, Kuller LH, Becker DJ, Orchard TJ. The progression of retinopathy over 2 years: The Pittsburgh Epidemiology of Diabetes Complications (EDC) Study. J Diabetes Complications. 1995;9: 14o–148.
  • Yanko L, Golbourt U, Michaelson IC, Shapiro A, Yaari S. Prevalence and 15-year incidence of retinopathy and associated characteristics in middle-aged and elderly diabetic men. Br J Ophthalmol. 1983;67: 759–765.
  • Ballard DJ, Melton LJ III, Dwyer MS, Trautmann JC, Chu CP, O'Fallon WM, Palumbo PJ. Risk factors for diabetic retinopathy: A population-based study in Rochester, Minnesota. Diabetes Care. 1986;9:334–342.
  • The Kroc Collaborative Study Groep. Blood glucose control and the evolution of diabetic retinopathy and albuminuria. A preliminary multicenter trial. N Engl J Med. 1984;311:365–372.
  • Lee ET, Lee VS, Kingsley RM, Lu M, Russell D, Asat NR, et al. Diabetic retinopathy in Oklahoma Indians with NIDDM: Incidence and risk factors. Diabetes Care. 1992;15: 1620–1627.
  • Norusis MJ. SPSS for Windows. Base System User's Guide Release 6.o. Chicago, Illinois: SPSS Inc., 1993.
  • Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Nat Cancer Inst. 1959;22:719–748.
  • Lee ET. Statistical methods for survival data analysis. New York: Wiley, 1992; 104–130.
  • Cox DR. Regression models and life table. J Roy Statist Soc. 1977;34: 187–220.
  • Gardner MI Altman DG. Statistics with confidence. London: British Medical Association, 1989.
  • Chen MS, Kao CS, Fu CC, Chen CI Tai TY. Incidence and progression of diabetic retinopathy among non-insulin-dependent diabetic subjects: A 4-year follow-up. Int J EpidemioL 1995;24: 787–795.
  • Nielson NV. Diabetic retinopathy. II. The course of retinopathy in diabetics treated with oral hypoglycaemic agents and diet regimen alone. A one-year epidemiological cohort study of diabetes mellitus. The Island of Falster, Denmark. Acta Ophthalmol. 1984;62:266–273.
  • Klein R, Klein BEK, Moss SE, Davis M, DeMets D. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. X. Four-year incidence and progression of diabetic retinopathy. Arch Ophthalmol. 1994; 112:1217–1228.
  • Klein R, Klein BEK, Moss SE, Cruickshanks KJ. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XIV. Ten-year incidence and progression of diabetic retinopathy when age at diagnosis is 30 years or more. Ophthalmology. 1989;107:244–249.
  • Tudor SM, Hamman RF, Baron A, Johnson DW, Shetterly SM. Incidence and progression of diabetic retinopathy in Hispanic and non-Hispanic whites with type 2 diabetes. Diabetes Care. 1998;21: 53–61.
  • Janghorbani M, Jones RB, Murray KJ, Allison SR Incidence of and risk factors for diabetic retinopathy in diabetic clinic attenders. Ophthalmic EpidemioL 2001,8:309–325.
  • Pugh JA, Tuley MR, Hazuda HP, Stern MR The influence of outpatient insurance coverage on the microvascular complications of non-insulin-dependent diabetes in Mexican Americans. J Diabetes Complications. 1992;6:236–241.
  • Kornerup T. Studies in retinopathy. An investigation of 1000 cases of diabetes. Acta Med Scand. 1955;37: 81—tot.
  • Balodimos MC, Aiello LM, Gleason RE. Retinopathy in mild diabetes of long duration. Arch OphthalmoL 1969;81:660–666.
  • Nilsson SE, Nilsson JE, Frostberg E. The Kristanstad Survey. 11. Studies in a representative adult control group. Acta Med Scand SuppL 1967;409: 1–42.
  • West KM, Erdreich J, Stober JA. A detailed study of risk factors for retinopathy and nephropathy in diabetes. Diabetes. 1980;29: 501–508.
  • Newell SW, Tolbert B, Bennett J, Parsley TL. The prevalence and risk of diabetic retinopathy among Indians of Southwest Oklahoma. J Okla State Med Assoc. 1989;82: 414–424.
  • University Group Diabetes Program. A study of the effect of hypoglycaemic agents on vascular complications in patients with adult onset diabetes. Diabetes. 1982; 31 (suppl 5):I–81.
  • Howard-Williams J, Hillson RM, Bron A, Audry P, Mann JI, Hockaday TDR. Retinopathy is associated with higher glycaemia in maturity-onset type diabetes. Diabetologia 1984;27:198–202.
  • Klein R. Diabetes retinopathy. Ann Rev Public Health. 1996;17: 137–158.
  • Ohkubo Y, Kishikawa H, Araki E, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: A randomised prospective 6-year study. Diabetes Res Clin Pract. 1995; 28:103–117.
  • UKPDS Group. UK Prospective Diabetes Study 17: A nine-year update of a randomised controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus. Ann Intern Med. 1996;124: 136–145.
  • UKPDS Group. UK Prospective Diabetes Study Group 33. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in-patients with type 2 diabetes. Lancet. 1998; 352:837–853.
  • Amini M, Bashardost N, Kazemi M, Shahparian M, Afshinnia F, Kabirzadeh M. Risk factors of diabetes mellitus among Isfahan city population aged over 40. Res Med Sci J (Farsi). 1998;2(5): 3–7.
  • Oakley WG, Pyke DA, Tattersall RB, Watkins PJ. Long term diabetes. Q J Med. 1974;43:145–156.
  • Knowler WC, Bennet PH, Ballantine EJ. Increased incidence of retinopathy in diabetics with elevated blood pressure. N Engl J Med. 1980;302:645–650.
  • Paetkau ME, Boyd TAS, Winship B, Grace M. Cigarette smoking and diabetic retinopathy. Diabetes. 1977; 26:46–49.
  • Chaturvedi N, Stephenson JM, Fuller JH. The relationship between smoking and microvascular complications in the EURODIAB IDDM Complications Study. Diabetes Care. 1995;18: 785–792.
  • West KM, Erdreich LS, Stober JA. Absence of a relationship between smoking and diabetic microangiopathy. Diabetes Care. 1980;3:250–252.
  • Rabb ME Gagliano DA, Sweeney HE. Diabetic retinopathy in blacks. Diabetes Care. 1990;13: 1202–1206.
  • Moss SE, Klein R, Klein BEK. Association of cigarette smoking with diabetic retinopathy. Diabetes Care. 1991;14:119–126.
  • Klein R, Klein BEK, Davis MD. Is cigarette smoking associated with diabetic retinopathy? Am J Epidemiol. 1983;118:228–238.
  • Barnett AH, Britton JR, Leatherdale BA. Study of possible risk factors for severe retinopathy in non-insulin-dependent diabetes. Br Med J. 1983;287:529.
  • Moss SE, Klein R, Klein BEK. Cigarette smoking and ten-year progression of diabetic retinopathy. Ophthalmology. 1996;103: 1438–1442.
  • Amini M, Amin-al-Roaia A, Rezvanian H, Kachooiee A, Safaiee H, Horn i N, Afshinnia F, Sattar G. Evaluation of glycaemic status in patients with known diabetes mellitus type I & II in Isfahan city during 1997. Res Med Sci J (Farsi). 1998;2(5):8–12.
  • Hurwitz B, Yudkin J. Diabetes care: Whose responsibility? Br Med J. 1984;289:1000-1001.
  • Stephenson J, Fuller JH. Microvascular and acute complications in IDDM patients: The EURODIAB IDDM Complications Study. Diabetologia. 1994;37:278–285.
  • Photocoagulation treatment of proliferative diabetic retinopathy. Clinical application of diabetic retinopathy study (DRS) findings, DRS report number 8. Ophthalmology. 1981;88:583-60o.
  • Blankenship GW. Fifteen-year argon laser and xenon photocoagulation results of Bascom Palmer Eye Institute's patients participating in the diabetic retinopathy study. Ophthalmology. 199198: 125–128.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.